← Latest news 
Bayer to push harder on tiered pricing for its drugs in India
Business
Published on 24 April 2026
Tiered pricing could reshape access and margins fast
In an exclusive interview, Bayer’s global head of pharmaceuticals, Stefan Oelrich, said the company will intensify its push for tiered pricing in India. The move is linked to Bayer’s “tailormade India” portfolio and its broader investment plans in innovation, aiming to balance affordability with business sustainability.
- Bayer plans to intensify tiered drug pricing in India
- The approach ties to its tailormade India portfolio
- Innovation investment remains central to its pharma strategy
- The interview outlines broader commercial and market goals
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times